Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is an expanded access treatment protocol designed to provide a topical cream treatment
option to military health care beneficiaries with parasitologically confirmed uncomplicated
Cutaneous Leishmaniasis.
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command